In This Section

Spotlight on Clinical Trials

CLINICAL TRIAL PRESENTations 

More than 240 clinical trials were presented at the AACR Annual Meeting 2023, including 17 trials presented in four Clinical Trials Plenary Sessions. Detailed summaries of these sessions are available through AACR Annual Meeting News:

Harnessing the Immune System in the Clinic

Five successful trials highlighted different approaches to tweak the immune system and improve clinical outcomes.

Learn More
Hope for Rare Cancers: Novel Targeted and Immunotherapy Agents

Four promising studies showcased novel targeted and immunotherapy agents for less common cancer types.

Learn More
Early Phase Clinical Trials

Researchers presented four antitumor treatments that have shown early promise in kidney, head and neck, and prostate cancers as well as multiple myeloma.

Learn More
Novel Biomarker-driven Molecularly Targeted Therapy Trials

Four trials offered new approaches for difficult-to-treat adult and pediatric cancers.

Learn More

Additional Clinical Trials Coverage from the AACR Blog

ONLINE PUBLICATION OF Clinical Trial ABSTRACTS  

All presented clinical trial abstracts were published in an online-only supplement to the AACR journal Cancer Research on April 14, 2023. Clinical trial abstracts are also available in PDF format for download.

View the Clinical Trial Abstracts in the Cancer Research Online Supplement Download the Clinical Trial Abstracts in PDF Format

Clinical trial abstracts are also available through the online program planner:

CLINICAL TRIALS (INCLUDING COMBINATION TRIALS) ABSTRACT CATEGORIES  

Clinical trial abstract presentations in the following categories were considered for presentation at the AACR Annual Meeting 2023:

  • CT01 Clinical Trials in Progress
    • Phase I clinical trials in progress 
    • Phase II clinical trials in progress 
    • Phase III clinical trials in progress 
  • CT02 COVID-19, Cancer, and Clinical Trials (See also COVID01: COVID-19 and Cancer)
    • Clinical trials in progress 
    • Phase I 
    • Phase II 
    • Phase III 
    • Phase IV, observational, and expanded access 
  • CT03 First-in-Human Phase I Clinical Trials 
  • CT04 Phase I Adult Clinical Trials (See also ET07: Pharmacology, Pharmacogenetics, and Pharmacogenomics) 
  • CT05 Phase II Adult Clinical Trials 
  • CT06 Phase III Adult Clinical Trials 
  • CT07 Phase I, II, or III Clinical Trials in the Elderly 
  • CT08 Phase I, II, or III Clinical Trials in Minorities and Medically Underserved Populations 
  • CT09 Phase I, II, or III Clinical Trials in Pediatric Cancer (See also CL08: Pediatric Cancer Clinical Investigations; TB06: Pediatric Cancer Basic Science) 

PLACEHOLDER ABSTRACT CATEGORIES  

  • PL01 Clinical Trials for COVID-19
    • Phase I Clinical Trials 
    • Phase II Clinical Trials 
    • Phase III Clinical Trials 
    • Phase IV, Observational, and Expanded Access Clinical Trials 
  • PL02 First-in-Human Phase I Clinical Trials 
  • PL03 Phase I Adult Clinical Trials  
  • PL04 Phase II Adult Clinical Trials  
  • PL05 Phase III Adult Clinical Trials  
  • PL06 Phase I, II, or III Clinical Trials in the Elderly  
  • PL07 Phase I, II, or III Clinical Trials in Minorities and Medically Underserved Populations  
  • PL08 Phase I, II, or III Clinical Trials in Pediatric Cancer